Pender NDI Life Sciences Fund

Pender NDI Life Sciences Fund is a venture capital fund managed by Pender Ventures, the private equity arm of Vancouver-based PenderFund Capital Management. The fund specializes in the life sciences sector, investing in early to growth-stage companies across biotechnology, medical devices, and healthcare technology. It was established following Pender's acquisition of the management rights for the life sciences portfolio of the Working Opportunity Fund (WOF). The fund plays a critical role in the Canadian innovation ecosystem by providing capital and strategic guidance to healthcare-focused enterprises. Its historical portfolio includes notable Canadian life science successes such as Xenon Pharmaceuticals and Aurinia Pharmaceuticals.